Eric Hyllengren

Eric Hyllengren

Director of Finance/CFO at TENAYA THERAPEUTICS, INC.

Net worth: 147 630 $ as of 31/07/2026

51 year
Health Technology
Consumer Services

Profile

Eric Hyllengren is currently Chief Financial & Accounting Officer at Tenaya Therapeutics, Inc. since 2026.
Formerly, Mr. Hyllengren was Chief Financial & Accounting Officer at Zura Bio Ltd. from 2025 to 2026, Chief Financial, Operating & Accounting Officer at Atara Biotherapeutics, Inc. from 2024 to 2025, and Executive Director-Business Development at Amgen, Inc. from 2017 to 2018.
Mr. Hyllengren completed undergraduate studies at the University of Notre Dame and earned an MBA from Kellogg School of Management.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
10/03/2026 17,617 ( 0.2% ) 147 630 $ 31/07/2026

Eric Hyllengren active positions

CompaniesPositionStart
TENAYA THERAPEUTICS, INC. Director of Finance/CFO 13/07/2026

Former positions of Eric Hyllengren

CompaniesPositionEnd
ZURA BIO LIMITED Director of Finance/CFO 20/04/2026
ATARA BIOTHERAPEUTICS, INC. Director of Finance/CFO 31/03/2025
AMGEN INC. Corporate Officer/Principal 01/01/2018
See the detail of Eric Hyllengren's experience

Training of Eric Hyllengren

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

58

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Eric Hyllengren